Atea Pharmaceuticals, Inc.AVIRNASDAQ
Loading
Income Before Tax Over TimeContracting
Percentile Rank14
Studio
Year-over-Year Change

Pre-tax earnings

Latest
$-164.51M
↓ 173% vs avg
Percentile
P14
Within normal range
Streak
1 yr
Consecutive growthContracting
Average
$-60.23M
Historical baseline
PeriodValueYoY Change
TTM$-164.51M+1.8%
2024$-167.46M-24.1%
2023$-134.94M-12.9%
2022$-119.50M-186.2%
2021$138.59M+1366.0%
2020$-10.95M+22.0%
2019$-14.03M-54.8%
2018$-9.06M-